5-(3,4-dimethylphenyl)-1,3,4-oxadiazole-2-thiol, 95.0%, 250mg

6-CYANO-4-CHROMANONE, 95.0%, 25g

N-Ethyl-3-methylbenzenesulfonamide, 95.0%, 500g

3,5-Dibenzyloxybenzaldehyde>98.0%(GC)5g

methyl 5-(1,3-benzodioxol-5-yl)isoxazole-3-carboxylate, 95.0%, 250mg

{1-AZABICYCLO[2.2.2]OCTAN-4-YLMETHANOL, 95%, 10g

5-(PROPAN-2-YL)-1,2,3-THIADIAZOLE-4-CARBOXYLIC ACID, 95.0%, 1g

1-(3-Bromobenzyl)piperidine, 97.0%, 1g

3-amino-3-[4-(methylthio)phenyl]propanoic acid, 95.0%, 5g

3-(N-BOC-METHYLAMINOMETHYL)AZETIDINE HCL, 95.0%, 5g

5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylic acid, 95.0%, 250mg

Colonne HPLC NUCLEODUR® 100-3 C18 ec 3 µm, 100 mm, 4 mm, 1 pièce(s)

6,7-Dihydropyrazino[2,3-d]pyridazine-5,8-dione, 25mg